C17ORF63 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.647970E-01
Normal-vs-Stage2
2.405000E-01
Normal-vs-Stage3
9.760000E-01
Normal-vs-Stage4
1.546200E-01
Stage1-vs-Stage2
9.714200E-01
Stage1-vs-Stage3
2.545000E-01
Stage1-vs-Stage4
3.641800E-01
Stage2-vs-Stage3
1.656440E-01
Stage2-vs-Stage4
2.901400E-01
Stage3-vs-Stage4
1.864390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.722600E-01
Normal-vs-AfricanAmerican
2.544000E-01
Normal-vs-Asian
1.958440E-01
Caucasian-vs-AfricanAmerican
8.206200E-01
Caucasian-vs-Asian
4.266200E-01
AfricanAmerican-vs-Asian
7.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.486800E-01
Normal-vs-Female
2.636000E-01
Male-vs-Female
8.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.833600E-01
Normal-vs-Age(41-60Yrs)
6.572400E-02
Normal-vs-Age(61-80Yrs)
3.905600E-01
Normal-vs-Age(81-100Yrs)
2.909000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.706400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.830000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.657200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.320310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.694610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.579200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.349200E-01
Normal-vs-Daily Drinker
4.845400E-01
Normal-vs-Weekly Drinker
4.134000E-01
Normal-vs-Occasional Drinker
1.218400E-01
Normal-vs-Social Drinker
1.019590E-01
Non Drinker-vs-Daily Drinker
6.767000E-01
Non Drinker-vs-Weekly Drinker
6.522400E-01
Non Drinker-vs-Occasional Drinker
1.482800E-01
Non Drinker-vs-Social Drinker
2.146000E-01
Daily Drinker-vs-Weekly Drinker
4.554800E-01
Daily Drinker-vs-Occasional Drinker
1.000040E-01
Daily Drinker-vs-Social Drinker
1.416980E-01
Weekly Drinker-vs-Occasional Drinker
6.086000E-01
Weekly Drinker-vs-Social Drinker
7.082800E-01
Occasional Drinker-vs-Social Drinker
8.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.642260E-02
Normal-vs-Grade 2
3.220700E-03
Normal-vs-Grade 3
3.316700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.205000E-01
Grade 1-vs-Grade 3
2.944400E-02
Grade 1-vs-Grade 4
1.642260E-02
Grade 2-vs-Grade 3
2.508400E-01
Grade 2-vs-Grade 4
3.220700E-03
Grade 3-vs-Grade 4
3.316700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.661200E-01
Normal-vs-NonDiabetic
1.615030E-01
Diabetic-vs-NonDiabetic
2.553800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.782000E-02
Normal-vs-NoPancreatitis
3.000400E-01
Pancreatitis-vs-NoPancreatitis
8.704200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.781440E-01
Normal-vs-N1
2.750200E-01
N0-vs-N1
9.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.173600E-02
Normal-vs-TP53-NonMutant
3.866600E-01
TP53-Mutant-vs-TP53-NonMutant
4.355500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
